The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania

BACKGROUND: Between 2007 and 2013, the Tanzanian public sector received 93.1 million doses of first-line anti-malarial artemisinin-based combination therapy (ACT) in the form of artemether-lumefantrine entirely supplied by funding partners. The introduction of a health facility ACT stock monitoring...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mikkelsen-Lopez, Inez, Shango, Winna, Barrington, Jim, Ziegler, Rene, Smith, Tom, deSavigny, Don
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2014
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030285/
https://ncbi.nlm.nih.gov/pubmed/24885420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-13-181
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items